Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma

Head and Neck

Volumn 35, Issue 10, 2013, Pages 1373-1378

  Wu, Hao ^a   Xu, Huiming ^a   Zhang, Shu ^a   Wang, Xudong ^a   Zhu, Huijun ^a   Zhang, Huilin ^b   Zhu, Jin ^c   Huang, Jianfei ^a  

^a NANTONG UNIVERSITY   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

laryngeal neoplasms; prognosis; squamous cell carcinoma; TROP2; tumor marker

Indexed keywords

MEMBRANE ANTIGEN; MESSENGER RNA; TROPHOBLASTIC CELL SURFACE ANTIGEN 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX SQUAMOUS CELL CARCINOMA; LIFESPAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION;

LARYNGEAL NEOPLASMS; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TROP2; TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 84872817120     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23138     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.
3. Argiris A, Eng C,. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 2003; 114: 15-60.
4. Takes RP, Baatenburg De Jong RJ, Alles MJ, et al. Markers for nodal metastasis in head and neck squamous cell cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 512-518.
5. Renkvist N, Castelli C, Robbins PF,. A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 2001; 50: 3-15.
6. Bodey B,. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy. Expert Opin Biol Ther 2002; 2: 577-584.
7. Ripani E, Sacchetti A, Corda D, Alberti S,. Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer 1998; 76: 671-676.
8. El Sewedy T, Fornaro M, Alberti S,. Cloning of the murine TROP2 gene: conservation of a PIP2-binding sequence in the cytoplasmic domain of TROP-2. Int J Cancer 1998; 75: 324-330.
9. Faulk WP, Temple A, Lovins RE, Smith N,. Antigens of human trophoblasts: a working hypothesis for their role in normal and abnormal pregnancies. Proc Natl Acad Sci U S A 1978; 75: 1947-1951.
10. Linnenbach AJ, Wojcierowski J, Wu SA, et al. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733. Proc Natl Acad Sci U S A 1989; 86: 27-31.
11. Guerra E, Trerotola M, Dell'Arciprete R, et al. A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 2008; 68: 8113-8121.
12. Cubas R, Zhang S, Li M, Chen C, Yao Q,. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer 2010; 9: 253.
13. Fong D, Spizzo G, Gostner JM, et al. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 2008; 21: 186-191.
14. Nakashima K, Shimada H, Ochiai T, et al. Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 2004; 112: 1029-1035.
15. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M,. Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 2006; 12: 3057-3063.
16. Fong D, Moser P, Krammel C, et al. High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 2008; 99: 1290-1295.
17. Wang JB, Day R, Dong YY, Weintraub SJ, Michel L,. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Therapeut 2008; 7: 280-285.
18. Fang YJ, Lu ZH, Wang GQ, et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 2009; 24: 875-884.
19. Muhlmann G, Spizzo G, Gostner J, et al. TROP2 expression as prognostic marker for gastric carcinoma. J Clin Pathol 2009; 62: 152-158.
20. Bignotti E, Todeschini P, Calza S, et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur J Cancer 2010; 46: 944-953.
21. Lin H, Liang J, Zhang HL, et al. Preparation and characterization of human anti-Trop-2 engineering antibody Fab. Prog Biochem Biophys 2010; 37: 1101-1107.
22. Thompson L,. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J 2006; 85: 74.
23. Tang Q, Liu YF, Zhu XJ, et al. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocollular carcinoma. Hum Pathol 2009; 40: 300-305.
24. Pastorcic-Grgic M, Sarcevic B, Dosen D, Juretic A, Spagnoli GC, Grgic M,. Prognostic value of MAGE-A and NY-ESO-1 expression in pharyngeal cancer. Head Neck 2010; 32: 1178-1184.
25. Lubin JH, Gaudet MM, Olshan AF, et al. Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. Am J Epidemiol 2010; 171: 1250-1261.
26. Lipinski M, Parks DR, Rouse RV, Herzenberg LA,. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc Natl Acad Sci U S A 1981; 78: 5147-5150.
27. Tomasino RM, Bazan V, Daniele E, et al. Biological characterization of laryngeal squamous-cell carcinoma. Anticancer Res 1996; 16: 2257-2267.
28. Kubrak J, Jarema A, Falco M, Rogowska D, Rubik A, Torbe B,. An analysis of factor influencing the outcome of patients with locally advanced larynx cancer. Otolaryngol Pol 2008; 62: 691-694.
29. Papadas TA, Alexopoulos EC, Mallis A, Jelastopulu E, Mastronikolis NS, Goumas P,. Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 2010; 267: 1095-1101.
30. Yilmaz T, Hosal AS, Gedikoglu G, Onerci M, Gursel B,. Prognostic significance of vascular and perineural invasion in cancer of the larynx. Am J Otolaryngol 1998; 19: 83-88.
31. Danic D, Maruic M, Uzarevic B, Milicic D,. Prognostic factors in squamous cell carcinoma of the larynx. ORL J Otorhinolaryngol Relat Spec 2000; 62: 143-148.
32. Fornaro M, Dell'Arciprete R, Stella M, et al. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 1995; 62: 610-618.
33. Terrinoni A, Dell'Arciprete R, Fornaro M, Stella M, Alberti S,. The cyclin D1 gene contains a cryptic promoter that is functional in human cancer cells. Genes Chromosomes Cancer 2001; 31: 209-220.